US Patent Issued to LENTIGEN TECHNOLOGY on July 22 for "Compositions and methods for treating cancer with DuoCARs" (American, German Inventors)

ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,718, issued on July 22, was assigned to LENTIGEN TECHNOLOGY INC. (Gaithersburg, Md.).

"Compositions and methods for treating cancer with DuoCARs" was invented by Rimas J. Orentas (Seattle), Dina Schneider (Potomac, Md.), Waleed M. Haso (Santa Monica, Calif.), Stefan Miltenyi (Bergisch Gladbach, Germany) and Boro Dropulic (Ellicott City, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Novel therapeutic immunotherapy compositions comprising at least two vectors, each vector encoding a functional CAR, whereby the combination of vectors results in the expression of two or more non-identical binding domains, wherein each vector encoded binding domain(...